Carcinoembryonic Antigen (Cea) Market Share, Key Trends, Vendor Strategies, Application Analysis, Regional Outlook & Forecasts to 2022

Hexa Reports

Market Research Reports and Insightful Company Profiles

Carcinoembryonic Antigen (CEA) Market Share, Key

Trends, Vendor Strategies, Application Analysis, Regional

Outlook & Forecasts to 2022

Global carcinoembryonic antigen market is expected to reach USD 2.56 Billion by 2022. Constant

technological advancements pertaining to the development of novel biomarkers which can be used in

combination with other biomarkers is expected to boost usage rates over the forecast period.

Furthermore, the increasing prevalence of cancer is expected to heighten the demand for effective

diagnostic tools.

According to the WHO estimates in 2012, global cancer incidences were nearly 14.1 million, which

include 6.7 million female patients and 7.4 million male patients. Increasing demand for minimally

invasive diagnostics procedures is also expected to play a vital role in determining market growth.

Browse Detail Report With TOC @ http://www.hexareports.com/report/carcinoembryonic-antigencea-market-analysis-by-application-colorectal-pancreatic-ovarian-breast-thyroid-cancer-and-segmentforecasts-to-2022

Key advantages associated with minimally invasive diagnostics procedures include elevated patient

satisfaction levels as they entail minor incision wounds. In addition, these procedures involve relatively

lesser hospital stays and therefore, are economically viable and involve fewer post procedure

complications.

Hexa Reports

Market Research Reports and Insightful Company Profiles

Further key findings from the study suggest:

Colorectal cancer was one of the largest revenue generating application segment of the

carcinoembryonic antigen market and was estimated at USD 639.65 million in 2014. Increasing

prevalence of colorectal cancer and usage of carcinoembryonic antigen tests at various stages is one of

the critical factors accounting for its large share. For instance, in 2012, new cases of colorectal cancer

were estimated to be over 93,000 and death due to colorectal cancer...